John A. Colwell

Title
InstitutionMedical University of South Carolina
DepartmentEndocrinology
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS, Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS, American Diabetes Association, American Heart Association, American College of Cardiology Foundation. Aspirin for primary prevention of cardiovascular events in people with diabetes. J Am Coll Cardiol. 2010 Jun 22; 55(25):2878-86. PMID: 20579547.
      Citations:    
    2. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS, Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS, American Diabetes Association, American Heart Association, American College of Cardiology Foundation. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care. 2010 Jun; 33(6):1395-402. PMID: 20508233; PMCID: PMC2875463.
      Citations:    
    3. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS, Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010 Jun 22; 121(24):2694-701. PMID: 20508178.
      Citations:    
    4. Colwell JA, Colwell JA. Does aspirin use reduce cardiovascular risk in diabetes? Nat Rev Endocrinol. 2009 Apr; 5(4):188-90. PMID: 19352314.
      Citations:    
    5. Mountford WK, Lackland DT, Soule JB, Hunt KJ, Lipsitz SR, Colwell JA, Mountford WK, Lackland DT, Soule JB, Hunt KJ, Lipsitz SR, Colwell JA. Racial disparities in trends for cardiovascular disease and procedures among hospitalized diabetic patients. Ethn Dis. 2008; 18(2):131-5. PMID: 18507262.
      Citations:    
    6. Mountford WK, Soule JB, Lackland DT, Lipsitz SR, Colwell JA, Mountford WK, Soule JB, Lackland DT, Lipsitz SR, Colwell JA. Diabetes-related lower extremity amputation rates fall significantly in South Carolina. South Med J. 2007 Aug; 100(8):787-90. PMID: 17713304.
      Citations:    
    7. Colwell JA, Colwell JA. An appraisal of aspirin therapy in diabetes. Curr Diab Rep. 2006 Dec; 6(6):409-10. PMID: 17118221.
      Citations:    
    8. Colwell JA, Colwell JA. Aspirin for the primary prevention of cardiovascular events. Timely Top Med Cardiovasc Dis. 2006 Oct 01; 10:E25. PMID: 17066145.
      Citations:    
    9. Koopman RJ, Mainous AG, Liszka HA, Colwell JA, Slate EH, Carnemolla MA, Everett CJ, Koopman RJ, Mainous AG, Liszka HA, Colwell JA, Slate EH, Carnemolla MA, Everett CJ. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med. 2006 Sep-Oct; 4(5):427-32. PMID: 17003143; PMCID: PMC1578655.
      Citations:    
    10. Colwell JA, Colwell JA. Aspirin for the primary prevention of cardiovascular events. Drugs Today (Barc). 2006 Jul; 42(7):467-79. PMID: 16894401.
      Citations:    
    11. Colwell JA, Colwell JA. Is aspirin effective in diabetic patients? Yes. J Thromb Haemost. 2005 Dec; 3(12):2612-4. PMID: 16359499.
      Citations:    
    12. Colwell JA, Colwell JA. Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. Am J Cardiovasc Drugs. 2004; 4(2):87-106. PMID: 15049721.
      Citations:    
    13. Colwell JA, Colwell JA, American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care. 2004 Jan; 27 Suppl 1:S72-3. PMID: 14693931.
      Citations: 37     Fields:    Translation:Humans
    14. Colwell JA, Colwell JA. Aspirin for primary prevention of cardiovascular events in diabetes. Diabetes Care. 2003 Dec; 26(12):3349-50. PMID: 14633827.
      Citations: 1     Fields:    Translation:Humans
    15. Colwell JA, Nesto RW, Colwell JA, Nesto RW. The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care. 2003 Jul; 26(7):2181-8. PMID: 12832332.
      Citations: 74     Fields:    Translation:HumansCells
    16. Colwell JA, Colwell JA, American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care. 2003 Jan; 26 Suppl 1:S87-8. PMID: 12502626.
      Citations: 18     Fields:    Translation:Humans
    17. Colwell JA, Colwell JA. Hemoglobin A1c is not the only issue. Curr Diab Rep. 2002 Aug; 2(4):295-6. PMID: 12643188.
      Citations:    Fields:    Translation:Humans
    18. Colwell JA, Colwell JA. Treatment for the procoagulant state in type 2 diabetes. Endocrinol Metab Clin North Am. 2001 Dec; 30(4):1011-30. PMID: 11727398.
      Citations: 8     Fields:    Translation:HumansCells
    19. Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK, Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care. 2000 Oct; 23(10):1478-85. PMID: 11023140.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    20. Pitale SU, Abraira C, Emanuele NV, McCarren M, Henderson WG, Pacold I, Bushnell D, Colwell JA, Nuttall FQ, Levin SR, Sawin CT, Comstock JP, Silbert CK, Pitale SU, Abraira C, Emanuele NV, McCarren M, Henderson WG, Pacold I, Bushnell D, Colwell JA, Nuttall FQ, Levin SR, Sawin CT, Comstock JP, Silbert CK. Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 2000 Sep; 23(9):1316-20. PMID: 10977025.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    21. Colwell JA, Keisler D, Todd-Heckel E, Arnold P, Jenkins C, Colwell JA, Keisler D, Todd-Heckel E, Arnold P, Jenkins C. New legislation covers reimbursement and diabetes care guidelines. J S C Med Assoc. 2000 Sep; 96(9):382-5. PMID: 11043014.
      Citations:    Fields:    Translation:Humans
    22. Azad N, Emanuele NV, Abraira C, Henderson WG, Colwell J, Levin SR, Nuttall FQ, Comstock JP, Sawin CT, Silbert C, Rubino FA, Azad N, Emanuele NV, Abraira C, Henderson WG, Colwell J, Levin SR, Nuttall FQ, Comstock JP, Sawin CT, Silbert C, Rubino FA. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications. 1999 Sep-Dec; 13(5-6):307-13. PMID: 10765007.
      Citations: 49     Fields:    Translation:HumansCTClinical Trials
    23. Colwell JA, Colwell JA. Aspirin and risk of hemorrhagic stroke. JAMA. 1999 Aug 25; 282(8):731-2; author reply 732-3. PMID: 10463702.
      Citations:    Fields:    Translation:Humans
    24. Emanuele N, Azad N, Abraira C, Henderson W, Colwell J, Levin S, Nuttall F, Comstock J, Sawin C, Silbert C, Marcovina S, Lee HS, Emanuele N, Azad N, Abraira C, Henderson W, Colwell J, Levin S, Nuttall F, Comstock J, Sawin C, Silbert C, Marcovina S, Lee HS. Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus. Arch Intern Med. 1998 Dec 7-21; 158(22):2485-90. PMID: 9855387.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    25. Colwell JA, Keisler D, Jenkins C, Boateng Y, Arnold P, Lackland D, Zheng D, Wheeler FC, Rosebrock G, Smith SH, Colwell JA, Keisler D, Jenkins C, Boateng Y, Arnold P, Lackland D, Zheng D, Wheeler FC, Rosebrock G, Smith SH. Overview of the Diabetes Initiative of South Carolina. J S C Med Assoc. 1998 Nov; 94(11):468-72. PMID: 9844311.
      Citations:    Fields:    Translation:Humans
    26. Willi SM, O'Rear D, Garvey WT, Colwell JA, Buse MG, Jaffa A, Lopes-Virella M, Wood D, Mayfield RK, Wallace P, Hermayer KL, Jenkins AJ, Lyons T, Mayer-Davis E, Willi SM, O'Rear D, Garvey WT, Colwell JA, Buse MG, Jaffa A, Lopes-Virella M, Wood D, Mayfield RK, Wallace P, Hermayer KL, Jenkins AJ, Lyons T, Mayer-Davis E. Diabetes research in South Carolina: past, present, and future. J S C Med Assoc. 1998 Nov; 94(11):502-8. PMID: 9844316.
      Citations:    Fields:    Translation:Humans
    27. Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK, Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM). Diabetes Care. 1998 Apr; 21(4):574-9. PMID: 9571345.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    28. Abraira C, Colwell JA, Nuttall F, Emanuele N, Comstock J, Levin S, Sawin C, Silbert C, Abraira C, Colwell JA, Nuttall F, Emanuele N, Comstock J, Levin S, Sawin C, Silbert C. A critical issue. Intensive insulin treatment and macrovascular disease. Diabetes Care. 1998 Apr; 21(4):669-71. PMID: 9571364.
      Citations:    Fields:    Translation:Humans
    29. Agrawal L, Emanuele NV, Abraira C, Henderson WG, Levin SR, Sawin CT, Silbert CK, Nuttall FQ, Comstock JP, Colwell JA, Agrawal L, Emanuele NV, Abraira C, Henderson WG, Levin SR, Sawin CT, Silbert CK, Nuttall FQ, Comstock JP, Colwell JA. Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 1998 Apr; 21(4):510-5. PMID: 9571333.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    30. Orr RK, Hoehn JL, Col NF, Colwell JA. Prevention of diabetes complications. Clin Cornerstone. 1998; 1(3):58-71. PMID: 10682173.
      Citations: 1     Fields:    Translation:Humans
    31. Colwell JA, Colwell JA. Elevated plasma homocysteine and diabetic vascular disease. Diabetes Care. 1997 Dec; 20(12):1805-6. PMID: 9405897.
      Citations:    Fields:    Translation:Humans
    32. Zheng D, Learner M, Wheeler FC, Macera CA, Boateng Y, Shepard DM, Colwell JA, Zheng D, Learner M, Wheeler FC, Macera CA, Boateng Y, Shepard DM, Colwell JA. Preventive care among people with diabetes in biracial population. J S C Med Assoc. 1997 Dec; 93(12):443-7. PMID: 9439106.
      Citations:    Fields:    Translation:Humans
    33. Colwell JA, Colwell JA. Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism. 1997 Dec; 46(12 Suppl 1):1-4. PMID: 9439550.
      Citations: 2     Fields:    Translation:Humans
    34. Colwell JA, Colwell JA. Controlling type 2 diabetes: are the benefits worth the costs? JAMA. 1997 Nov 26; 278(20):1700. PMID: 9388092.
      Citations: 2     Fields:    Translation:Humans
    35. Orr RK, Hoehn JL, Col NF, Colwell JA. Aspirin therapy in diabetes. Diabetes Care. 1997 Nov; 20(11):1767-71. PMID: 9353620.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    36. Colwell JA, Colwell JA. Pharmacological strategies to prevent macrovascular disease in NIDDM. Diabetes. 1997 Sep; 46 Suppl 2:S131-4. PMID: 9285515.
      Citations: 1     Fields:    Translation:Humans
    37. Colwell JA, Colwell JA. Aspirin therapy in diabetes mellitus. Diabetologia. 1997 Jul; 40(7):867. PMID: 9243111.
      Citations:    Fields:    Translation:Humans
    38. Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS, Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med. 1997 Jan 27; 157(2):181-8. PMID: 9009975.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    39. Orr RK, Hoehn JL, Col NF, Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study. Diabetes Care. 1996 Dec; 19(12):1375-81. PMID: 8941467.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    40. Colwell JA, Colwell JA. Should we use intensive insulin therapy after oral agent failure in type II diabetes? Diabetes Care. 1996 Aug; 19(8):896-8. PMID: 8842613.
      Citations: 1     Fields:    Translation:Humans
    41. Colwell JA, Colwell JA. Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes. 1996 Jul; 45 Suppl 3:S87-90. PMID: 8674902.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    42. Colwell JA, Clark CM, Colwell JA, Clark CM. Forum Two: Unanswered research questions about metabolic control in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996 Jan 01; 124(1 Pt 2):178-9. PMID: 8554215.
      Citations:    Fields:    Translation:Humans
    43. Colwell JA, Colwell JA. The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM. Ann Intern Med. 1996 Jan 01; 124(1 Pt 2):131-5. PMID: 8554205.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    44. Jokl R, Klein RL, Lopes-Virella MF, Colwell JA, Jokl R, Klein RL, Lopes-Virella MF, Colwell JA. Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes. Diabetes Care. 1995 Aug; 18(8):1150-5. PMID: 7587850.
      Citations: 4     Fields:    Translation:HumansCells
    45. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS, Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995 Aug; 18(8):1113-23. PMID: 7587846.
      Citations: 59     Fields:    Translation:HumansAnimalsCTClinical Trials
    46. Jokl R, Laimins M, Klein RL, Lyons TJ, Lopes-Virella MF, Colwell JA, Jokl R, Laimins M, Klein RL, Lyons TJ, Lopes-Virella MF, Colwell JA. Platelet plasminogen activator inhibitor 1 in patients with type II diabetes. Diabetes Care. 1994 Aug; 17(8):818-23. PMID: 7956624.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    47. Colwell JA, Colwell JA. Is it time to introduce metformin in the U.S.? Diabetes Care. 1993 Apr; 16(4):653-5. PMID: 8462396.
      Citations: 3     Fields:    Translation:Humans
    48. Colwell JA, Colwell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes. 1993 Jan; 42(1):8-11. PMID: 8420821.
      Citations: 10     Fields:    Translation:Humans
    49. Vinik AI, Colwell JA, Vinik AI, Colwell JA. Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Hyperlipidemia in Diabetes Investigators. Diabetes Care. 1993 Jan; 16(1):37-44. PMID: 8422814.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    50. Laber-Laird K, Smith A, Swindle MM, Colwell J, Laber-Laird K, Smith A, Swindle MM, Colwell J. Effects of isoflurane anesthesia on glucose tolerance and insulin secretion in Yucatan minipigs. Lab Anim Sci. 1992 Dec; 42(6):579-81. PMID: 1479810.
      Citations: 4     Fields:    Translation:Animals
    51. Abraira C, Emanuele N, Colwell J, Henderson W, Comstock J, Levin S, Nuttall F, Sawin C, Abraira C, Emanuele N, Colwell J, Henderson W, Comstock J, Levin S, Nuttall F, Sawin C. Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM) Diabetes Care. 1992 Nov; 15(11):1560-71. PMID: 1308130.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    52. Colwell JA, Colwell JA. Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus. Metabolism. 1992 May; 41(5 Suppl 1):7-10. PMID: 1574016.
      Citations: 1     Fields:    Translation:HumansCells
    53. Colwell JA, Colwell JA. Clinical trials of antiplatelet agents in diabetes mellitus: rationale and results. Semin Thromb Hemost. 1991 Oct; 17(4):439-44. PMID: 1803515.
      Citations:    Fields:    Translation:Humans
    54. Colwell JA, Colwell JA. Pathophysiology of vascular disease in diabetes: effects of gliclazide. Am J Med. 1991 Jun 24; 90(6A):50S-54S. PMID: 1872305.
      Citations: 3     Fields:    Translation:HumansCells
    55. Colwell JA, Colwell JA. Oral treatment of diabetes mellitus: the contribution of gliclazide. Am J Med. 1991 Jun 24; 90(6A):1S-2S. PMID: 1872299.
      Citations: 1     Fields:    Translation:Humans
    56. Hornsby WG, Boggess KA, Lyons TJ, Barnwell WH, Lazarchick J, Colwell JA, Hornsby WG, Boggess KA, Lyons TJ, Barnwell WH, Lazarchick J, Colwell JA. Hemostatic alterations with exercise conditioning in NIDDM. Diabetes Care. 1990 Feb; 13(2):87-92. PMID: 2112452.
      Citations: 7     Fields:    Translation:Humans
    57. Colwell JA, Bingham SF, Abraira C, Anderson JW, Comstock JP, Kwaan HC, Nuttall F, Colwell JA, Bingham SF, Abraira C, Anderson JW, Comstock JP, Kwaan HC, Nuttall F. V.A. Cooperative Study of antiplatelet agents in diabetic patients after amputation for gangrene: unobserved, sudden, and unexpected deaths. J Diabet Complications. 1989 Oct-Dec; 3(4):191-7. PMID: 2533210.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    58. Watanabe J, Wohltmann HJ, Klein RL, Colwell JA, Lopes-Virella MF, Watanabe J, Wohltmann HJ, Klein RL, Colwell JA, Lopes-Virella MF. Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients. Diabetes. 1988 Dec; 37(12):1652-7. PMID: 3192039.
      Citations: 6     Fields:    Translation:HumansCells
    59. Colwell JA, Lopes-Virella MF, Colwell JA, Lopes-Virella MF. A review of the development of large-vessel disease in diabetes mellitus. Am J Med. 1988 Nov 28; 85(5A):113-8. PMID: 3057888.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    60. Colwell JA, Colwell JA. President's address. Diabetes. 1988 Nov; 37(11):1449-52. PMID: 3053300.
      Citations:    Fields:    Translation:Humans
    61. Colwell JA, Colwell JA. Antiplatelet agents and diabetic vascular disease. Trans Am Clin Climatol Assoc. 1987; 98:119-27. PMID: 3303615; PMCID: PMC2279735.
      Citations:    Fields:    Translation:HumansCells
    62. Lyons TJ, Baynes JW, Patrick JS, Colwell JA, Lopes-Virella MF, Lyons TJ, Baynes JW, Patrick JS, Colwell JA, Lopes-Virella MF. Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control. Diabetologia. 1986 Oct; 29(10):685-9. PMID: 3803742.
      Citations: 20     Fields:    Translation:Humans
    63. Colwell JA, Bingham SF, Abraira C, Anderson JW, Comstock JP, Kwaan HC, Nuttall F, Colwell JA, Bingham SF, Abraira C, Anderson JW, Comstock JP, Kwaan HC, Nuttall F. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care. 1986 Mar-Apr; 9(2):140-8. PMID: 3516608.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    64. Colwell JA, Bingham SF, Colwell JA, Bingham SF. VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis. Haemostasis. 1986; 16(6):433-8. PMID: 3556347.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    65. Halushka PV, Mayfield R, Colwell JA, Halushka PV, Mayfield R, Colwell JA. Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism. 1985 Dec; 34(12 Suppl 1):32-6. PMID: 3934501.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    66. Lopes-Virella MF, Sherer G, Wohltmann H, Sens D, Colwell JA, Lopes-Virella MF, Sherer G, Wohltmann H, Sens D, Colwell JA. Diabetic lipoprotein deficient serum: its effect in low density lipoprotein (LDL) uptake and degradation by fibroblasts. Metabolism. 1985 Dec; 34(12):1079-85. PMID: 2999561.
      Citations:    Fields:    Translation:HumansCells
    67. Mayfield RK, Halushka PV, Wohltmann HJ, Lopes-Virella M, Chambers JK, Loadholt CB, Colwell JA, Mayfield RK, Halushka PV, Wohltmann HJ, Lopes-Virella M, Chambers JK, Loadholt CB, Colwell JA. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes. 1985 Nov; 34(11):1127-33. PMID: 3930325.
      Citations: 6     Fields:    Translation:HumansCells
    68. Colwell JA, Bingham SF, Abraira C, Anderson JW, Kwaan HC, Colwell JA, Bingham SF, Abraira C, Anderson JW, Kwaan HC. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics. Horm Metab Res Suppl. 1985; 15:69-73. PMID: 3908283.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    69. Mayfield RK, Margolius HS, Levine JH, Wohltmann HJ, Loadholt CB, Colwell JA, Mayfield RK, Margolius HS, Levine JH, Wohltmann HJ, Loadholt CB, Colwell JA. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. J Clin Endocrinol Metab. 1984 Aug; 59(2):278-86. PMID: 6564131.
      Citations: 6     Fields:    Translation:Humans
    70. Colwell JA, Bingham SF, Abraira C, Anderson JW, Kwaan HC, Colwell JA, Bingham SF, Abraira C, Anderson JW, Kwaan HC. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics. Control Clin Trials. 1984 Jun; 5(2):165-83. PMID: 6378522.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    71. Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV, Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med. 1983 Nov 30; 75(5B):67-80. PMID: 6424441.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    72. Mayfield RK, Sullivan FM, Colwell JA, Wohltmann HJ, Mayfield RK, Sullivan FM, Colwell JA, Wohltmann HJ. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics. Diabetes. 1983 Oct; 32(10):908-14. PMID: 6352376.
      Citations: 1     Fields:    Translation:Humans
    73. Mordes DB, Lazarchick J, Colwell JA, Sens DA, Mordes DB, Lazarchick J, Colwell JA, Sens DA. Elevated glucose concentrations increase factor VIIIR:Ag levels in human umbilical vein endothelial cells. Diabetes. 1983 Sep; 32(9):876-8. PMID: 6414864.
      Citations: 5     Fields:    Translation:HumansCells
    74. Colwell JA, Winocour PD, Halushka PV, Colwell JA, Winocour PD, Halushka PV. Do platelets have anything to do with diabetic microvascular disease? Diabetes. 1983 May; 32 Suppl 2:14-9. PMID: 6242836.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    75. Lopes-Virella MF, Wohltmann HJ, Mayfield RK, Loadholt CB, Colwell JA, Lopes-Virella MF, Wohltmann HJ, Mayfield RK, Loadholt CB, Colwell JA. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study. Diabetes. 1983 Jan; 32(1):20-5. PMID: 6336700.
      Citations: 15     Fields:    Translation:Humans
    76. Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, LeRoy EC, Colwell JA, Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, LeRoy EC, Colwell JA. Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia. 1982 Jun; 22(6):430-6. PMID: 7049800.
      Citations: 21     Fields:    Translation:HumansCells
    77. Van Zile J, Kilpatrick M, Laimins M, Sagel J, Colwell J, Virella G, Van Zile J, Kilpatrick M, Laimins M, Sagel J, Colwell J, Virella G. Platelet aggregation and release of ATP after incubation with soluble immune complexes purified from the serum of diabetic patients. Diabetes. 1981 Jul; 30(7):575-9. PMID: 7250529.
      Citations: 9     Fields:    Translation:Humans
    78. Halushka PV, Mayfield R, Wohltmann HJ, Rogers RC, Goldberg AK, McCoy SA, Loadholt CB, Colwell JA, Halushka PV, Mayfield R, Wohltmann HJ, Rogers RC, Goldberg AK, McCoy SA, Loadholt CB, Colwell JA. Increased platelet arachidonic acid metabolism in diabetes mellitus. Diabetes. 1981; 30(Suppl 2):44-8. PMID: 6795072.
      Citations: 2     Fields:    Translation:HumansCells
    79. Colwell JA, Colwell JA. Atherosclerosis in diabetes mellitus. J Chronic Dis. 1981; 34(1):1-4. PMID: 7005253.
      Citations:    Fields:    Translation:HumansCells
    80. Colwell JA, Lopes-Virella M, Halushka PV, Colwell JA, Lopes-Virella M, Halushka PV. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care. 1981 Jan-Feb; 4(1):121-33. PMID: 7009108.
      Citations: 20     Fields:    Translation:HumansCells
    81. Colwell JA, Halushka PV, Colwell JA, Halushka PV. Platelet function in diabetes mellitus. Br J Haematol. 1980 Apr; 44(4):521-6. PMID: 6769461.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    82. Gonzalez J, Colwell JA, Sarji KE, Nair RM, Sagel J, Gonzalez J, Colwell JA, Sarji KE, Nair RM, Sagel J. Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus. Thromb Res. 1980 Jan 1-15; 17(1-2):261-6. PMID: 6990548.
      Citations: 6     Fields:    Translation:Humans
    83. Colwell JA, Nair RM, Halushka PV, Rogers C, Whetsell A, Sagel J, Colwell JA, Nair RM, Halushka PV, Rogers C, Whetsell A, Sagel J. Platelet adhesion and aggregation in diabetes mellitus. Metabolism. 1979 Apr; 28(4 Suppl 1):394-400. PMID: 122293.
      Citations: 10     Fields:    Translation:HumansCells
    84. Graves JM, Colwell JA, Nair RM, Sarji KE, Graves JM, Colwell JA, Nair RM, Sarji KE. The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjects. Clin Endocrinol (Oxf). 1977 Jun; 6(6):437-42. PMID: 301801.
      Citations:    Fields:    Translation:Humans
    85. Colwell JA, Sagel J, Crook L, Chambers A, Laimins M, Colwell JA, Sagel J, Crook L, Chambers A, Laimins M. Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with an without vascular disease. Metabolism. 1977 Mar; 26(3):279-85. PMID: 319323.
      Citations: 11     Fields:    Translation:HumansCellsCTClinical Trials
    86. Colwell JA, Halushka PV, Sarji K, Levine J, Sagel J, Nair RM, Colwell JA, Halushka PV, Sarji K, Levine J, Sagel J, Nair RM. Altered platelet function in diabetes mellitus. Diabetes. 1976; 25(2 SUPPL):826-31. PMID: 823064.
      Citations: 28     Fields:    Translation:HumansCells
    87. Colwell JA, Chambers A, Laimins M, Colwell JA, Chambers A, Laimins M. Inhibition of labile aggregation-stimulating substance (LASS) and platelet aggregation in diabetes mellitus. Diabetes. 1975 Jul; 24(7):684-7. PMID: 1158034.
      Citations: 4     Fields:    Translation:HumansCells
    88. Sagel J, Colwell JA, Crook L, Laimins M, Sagel J, Colwell JA, Crook L, Laimins M. Increased platelet aggregation in early diabetus mellitus. Ann Intern Med. 1975 Jun; 82(6):733-8. PMID: 1138583.
      Citations: 47     Fields:    Translation:Humans
    89. Sorensen LB, Tesar JT, Ellman MH, Colwell J, Sorensen LB, Tesar JT, Ellman MH, Colwell J. A new case of xanthinuria. Am J Med. 1972 Nov; 53(5):690-2. PMID: 5079766.
      Citations:    Fields:    Translation:Humans
    90. Kwaan HC, Colwell JA, Suwanwela N, Kwaan HC, Colwell JA, Suwanwela N. Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation. Diabetes. 1972 Feb; 21(2):108-13. PMID: 4621843.
      Citations: 13     Fields:    Translation:HumansCells
    91. Colwell JA, Cruz SR, Colwell JA, Cruz SR. Effect of resection of adipose tissue on the diabetes and hyperinsulinism of benign symmetric lipomatosis. Diabetes. 1972 Jan; 21(1):13-5. PMID: 5008082.
      Citations: 1     Fields:    Translation:Humans
    92. Colwell JA, Wilber JF, Colwell JA, Wilber JF. Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia. Diabetes. 1971 Sep; 20(9):607-14. PMID: 4328691.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    93. Colwell JA, Colwell JA. Pheochromocytoma and insulin. Ann Intern Med. 1969 Sep; 71(3):668-9. PMID: 5809699.
      Citations:    Fields:    Translation:Humans
    94. Colwell JA, Colwell JA. Inhibition of insulin secretion by catecholamines in pheochromocytoma. Ann Intern Med. 1969 Aug; 71(2):251-6. PMID: 5800291.
      Citations: 12     Fields:    Translation:Humans
    95. Colwell JA, Furey WL, Colwell JA, Furey WL. Insulin secretion by insuloma and normal pancreas slices. Studies in a patient with multiple endocrine adenomata. Diabetes. 1968 Feb; 17(2):83-9. PMID: 4295088.
      Citations: 3     Fields:    Translation:Humans
    96. Colwell JA, Lein A, Colwell JA, Lein A. Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes. 1967 Aug; 16(8):560-5. PMID: 6041184.
      Citations: 24     Fields:    Translation:Humans
    97. Colwell JA, Colwell JA. Effect of diabetic control on retinopathy. Diabetes. 1966 Jul; 15(7):497-9. PMID: 5329504.
      Citations: 9     Fields:    Translation:Humans
    98. Colwell JA, Colwell AR, Colwell JA, Colwell AR. Effect of insulin infusion of pancreas on blood glucose. Diabetes. 1966 Feb; 15(2):123-6. PMID: 5907155.
      Citations:    Fields:    Translation:Animals
    99. COLWELL JA, LEIN A, COLWELL JA, LEIN A. QUANTITATIVE RELATIONSHIP BETWEEN PLASMA CONCENTRATION OF FATTY ACIDS AND GLUCOSE IN NORMAL AND DIABETIC DOGS. Diabetes. 1963 Sep-Oct; 12:424-8. PMID: 14067740.
      Citations: 1     Fields:    Translation:AnimalsCells
    100. COLWELL JA, LEIN A, COLWELL JA, LEIN A. EFFECT OF SITE OF ADMINISTRATION OF INSULIN ON BLOOD GLUCOSE AND FATTY ACID CONCENTRATIONS. Diabetes. 1963 Jul-Aug; 12:319-22. PMID: 14081843.
      Citations: 1     Fields:    Translation:Animals
    101. Orr RK, Hoehn JL, Col NF, COLWELL JA, TILLMAN SP. Early recognition and therapy of disseminated coccidioidomycosis. Am J Med. 1961 Nov; 31:676-91. PMID: 13880720.
      Citations: 5     Fields:    Translation:Humans
    102. COLWELL JA, COLWELL JA. Remission in disseminated coccidiodomycosis produced by amphotericin B. Ann Intern Med. 1959 Apr; 50(4):1028-35. PMID: 13637573.
      Citations: 3     Fields:    Translation:Humans
    103. COLWELL AR, COLWELL JA, COLWELL AR, COLWELL JA. Intrapancreatic infusions of the sulfonylureas. Diabetes. 1957 Jan-Feb; 6(1):60; discussion, 62. PMID: 13397425.
      Citations:    Fields:    
    104. COLWELL AR, COLWELL AR, COLWELL JA, COLWELL AR, COLWELL AR, COLWELL JA. Intrapancreatic perfusion of the antidiabetic sulfonylureas. Metabolism. 1956 Nov; 5(6 Part 2):749-56. PMID: 13378043.
      Citations: 8     Fields:    
    Colwell's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (295)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _